Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.
Colloidal nanocarriers, in their various forms, have the possibility of providing endless opportunities in the area of drug delivery. The current communication embodies an in-depth discussion of colloidal nanocarriers with respect to formulation aspects, types, and site-specific drug targeting using various forms of colloidal nanocarriers with special insights to the field of oncology. Specialized nanotechnological approaches like quantum dots, dendrimers, integrins, monoclonal antibodies, and so forth, which have been extensively researched for targeted delivery of therapeutic and diagnostic agents, are also discussed. Nanotechnological patents, issued by the U.S. Patent and Trademark Office in the area of drug delivery, are also included in this review to emphasize the importance of nanotechnology in the current research scenario.


BACKGROUND
Colloidal nanocarriers provide almost endless opportunities in the area of drug delivery. While the review mainly addresses potential oncological applications, similar approaches may be applicable in other conditions with a requirement for targeted drug delivery. Technologies including quantum dots, dendrimers, integrins, monoclonal antibodies are discussed, along with US-based patents related to these methods.
Mishra
B
B
Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi, India. bmishra@bhu.ac.in
Patel
Bhavesh B
BB
Tiwari
Sanjay
S
D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003102:Colloids; D004337:Drug Carriers / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods*; D049329:Nanostructures / Q000737:chemistry*; D009369:Neoplasms / Q000473:pathology
D003102:Colloids; D004337:Drug Carriers